ArticleSurgical neurology international2025
BurstDR spinal cord stimulation for chronic inflammatory demyelinating polyneuropathy.
Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a neurological disorder in which the immune system attacks the myelin sheath, leading to progressive muscle weakness and sensory loss. Neuropathic pain is a common and often debilitating symptom in patients with CIDP. Treatment options include immunoglobulin therapy and, in refractory cases, spinal cord stimulation (SCS). Case Description: We present the case of a 70-year-old male with CIDP who experienced severe neuropathic pain in a stocking distribution affecting both lower extremities. He had previously been treated with intravenous immunoglobulin with limited relief of his pain symptoms. Due to persistent, debilitating neuropathic pain despite ongoing immunotherapy, he underwent implantation of a thoracic paddle spinal cord stimulator. At 3-month postoperative follow-up, he reported a 75% reduction in pain intensity. Conclusion: BurstDR paddle lead SCS may offer significant pain relief in patients with CIDP-associated neuropathic pain and should be considered as part of a multidisciplinary treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.